Acknowledgement
Supported by : Samsung Medical Center
References
- Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416. https://doi.org/10.1093/eurheartj/ehi044
- McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9. https://doi.org/10.1161/01.CIR.0000078641.19365.4C
- Senthilkumar A, Majmudar MD, Shenoy C, Kim HW, Kim RJ. Identifying the etiology: a systematic approach using delayedenhancement cardiovascular magnetic resonance. Heart Fail Clin 2009;5:349-67, vi. https://doi.org/10.1016/j.hfc.2009.02.009
- Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-8. https://doi.org/10.1016/S0140-6736(00)03567-4
- Yoon YE, Hong YJ, Kim HK, et al. 2014 Korean Guidelines for Appropriate Utilization of Cardiovascular Magnetic Resonance Imaging: a joint report of the Korean Society of Cardiology and the Korean Society of Radiology. Korean Circ J 2014;44:359-85. https://doi.org/10.4070/kcj.2014.44.6.359
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97. https://doi.org/10.1001/jama.285.19.2486
- National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002;106:3143-421.
- Janik M, Cham MD, Ross MI, et al. Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy. J Hypertens 2008;26:1677-85. https://doi.org/10.1097/HJH.0b013e328302ca14
- Cummings KW, Bhalla S, Javidan-Nejad C, Bierhals AJ, Gutierrez FR, Woodard PK. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics 2009;29:89-103. https://doi.org/10.1148/rg.291085052
- Jackson E, Bellenger N, Seddon M, Harden S, Peebles C. Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement. Clin Radiol 2007;62:395-403. https://doi.org/10.1016/j.crad.2006.11.013
- Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol 2009;55:1-16. https://doi.org/10.1016/j.jacc.2009.06.059
- Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol 1986;8:1467-70. https://doi.org/10.1016/S0735-1097(86)80325-4
- Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53. https://doi.org/10.1056/NEJM200011163432003
- Wagner A, Mahrholdt H, Thomson L, et al. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. J Am Coll Cardiol 2006;47:2027-33. https://doi.org/10.1016/j.jacc.2006.01.059
- Bax JJ, Visser FC, Poldermans D, et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 2001;104(12 Suppl 1):I314-8. https://doi.org/10.1161/hc37t1.094853
- Soriano CJ, Ridocci F, Estornell J, Jimenez J, Martinez V, De Velasco JA. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 2005;45:743-8. https://doi.org/10.1016/j.jacc.2004.11.037
- Calore C, Cacciavillani L, Boffa GM, et al. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown) 2007;8:821-9. https://doi.org/10.2459/JCM.0b013e3280101e3c
- Soriano CJ, Ridocci F, Estornell J, et al. Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience. Int J Cardiol 2007;116:167-73. https://doi.org/10.1016/j.ijcard.2006.03.040
- Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 2002;39:210-8.
- Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8. https://doi.org/10.1161/01.CIR.0000118493.13323.81
- Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260-4. https://doi.org/10.1016/j.jacc.2004.03.035
- Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002. https://doi.org/10.1161/01.CIR.100.19.1992
Cited by
- A speckle-tracking strain-based artificial neural network model to differentiate cardiomyopathy type vol.54, pp.2, 2020, https://doi.org/10.1080/14017431.2019.1678764